CompletedNot Applicable

Same Day Discharge Following Pelvic Reconstructive Surgery

United States54 participantsStarted 2021-06-14

Plain-language summary

This is a prospective cross-sectional study in which patients undergoing major pelvic reconstructive surgery with total vaginal hysterectomy will be recruited and enrolled. At approximately 2 weeks and 12 weeks postoperatively, enrolled patients will be asked to complete a survey detailing their experience with SDD, surgical recovery, and advice for prospective patients.

Who can participate

Age range18 Years

SexFEMALE

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * Total vaginal hysterectomy with or without bilateral salpingectomy/oophorectomy * Apical repair with uterosacral ligament suspension or sacrospinous ligament fixation * They may also have any of the following concurrent procedures: Anterior repair, Posterior repair, Enterocele repair, Suburethral sling for incontinence * Surgery by one of the fellowship trained urogynecologists at TriHealth * English speaking Exclusion Criteria: * Enrollment in the "Diazepam Research Study" (Protocol ID:19-130) * Concomitant procedure with another surgeon * Chronic pain conditions that require daily use of narcotic pain medications (including but not limited to: chronic back or pelvic pain, interstitial cystitis, fibromyalgia) * Concomitant anal sphincteroplasty, mesh removal or use of mesh for prolapse (excluding sling procedures)

What they're measuring

Number of subjects who satisfied with the results of the surgery

Timeframe: Approximately 2 weeks postoperatively

Trial details

NCT IDNCT04804826

SponsorTriHealth Inc.

Sponsor typeOTHER

Study typeOBSERVATIONAL

Primary completion2022-01-05

View on ClinicalTrials.gov More Same Day Discharge trials